For more information and to see if you may qualify
for these studies,
please contact Linda Jacobs at: (608)263-5213
Study #1
Title: Clinical Investigation of the DeBakey
VAD(r) for Bridging Patients to Cardiac Transplantation while
Waiting for a Donor Heart . PI: Niloo Edwards, MD, Coordinator:
Linda Jacobs
Study Summary
The purpose of this clinical research study is to determine whether
the DeBakey VAD(r) is safe and effective in assisting the heart
to pump blood in cardiac transplant candidates who are at risk
of imminent death while waiting for a donor heart. A VAD is a
ventricular assist device - a pump that helps the ventricle pump
blood to the rest of the body.
Study #2
Title: Randomized Clinical Trial of the Safety
and Efficacy of the DeBakey VAD(r) as an Destination Therapy in
Patients with End-Stage Heart Failure, PI: Niloo Edwards,
MD, Coordinator: Linda Jacobs
Study Summary
Purpose is to evaluate the safety and effectiveness of the DeBakey
VAD(r) left ventricular assist device (DeBakey VAD(r)) in providing
long-term circulatory support for individuals who have NYHA Class
IV heart failure symptoms (end stage heart failure) and are not
ineligible for a heart transplant.
Study #3
Title: A feasibility study to evaluate the short-term
safety and effectiveness of the catheter, sensor, transmitter,
and receiver
components of the LVP 1000 monitoring system in patients undergoing
open-chest cardiac surgery PI: Niloo Edwards, MD, Coordinator:
Linda Jacobs.
Study Summary
Purpose of this study is to evaluate a new device, the LVP 1000,
which will be used to monitor left ventricle pressure without
the patient having to be in the hospital. Testing of the device
will be on individuals who are undergoing a heart transplant.
Study #4
Title: Comparison of a de novo tacrolimus/sirolimus/prednisone
regimen versus tacrolimus/azathioprine/prednisone immunosuppressive
regimen in lung transplantation PI: Robert Love, MD Coordinator:
Linda Jacobs
Study Summary
The purpose of this study is to evaluate the effectiveness of
sirolimus as compared to azathioprine, both in combination with
tacrolimus and prednisone, in the prevention of acute rejection
in lung transplant recipients. All the medications used in this
study are commercially available immunosuppressive drugs that
are routinely used to prevent rejection following transplantation.
|
